Delivery Order SPE2DR25D1201-SPE2DR26FAJPT
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $12,467.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body 2.4ML injectable medication on October 22, 2025, with completion targeted for November 13, 2025. This non-set-aside delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the Defense Logistics Agency,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injectable medication, with a completion date of July 22, 2025. This is a firm fixed-price, non-set-aside contract awarded on June 30, 2025, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $12,604.63 for SKYRIZI 360 mg/2.4 ml on-body injectable pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of May 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $42,191.28 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen medication on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication in 2.4 mL quantities. The award, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, was made without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $23,660 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injectors on October 16, 2025, with completion targeted for November 6, 2025. This firm fixed-price, competitively awarded contract involves pharmaceutical supply to support military and federal healthcare operations. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injection medication. This non-set-aside contract, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a purchase of pharmaceutical supplies to support federal medical procurement needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJPTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,467.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed-price, non-set-aside contract awarded on October 27, 2025, with a completion deadline of November 18, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates consistent success in competing for open awards across multiple therapeutic domains, positioning it as a critical vendor within the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 10/27/25 |